Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"
15/21/15 AptarGroup, Inc. completed the acquisition of remaining 35.4% stake in Voluntis S.A.. CI
27/21/27 Global markets live: Intel, Apple, Rolls-Royce, Raytheon, MGM... Zonebourse
16/21/16 Global markets live: Thales, Nestlé, Evergrande, AMC, Walmart... Zonebourse
03/21/03 Global markets live: Amazon, Delivery Hero, Walmart, Broadcom, JD.com, Didi Global... Zonebourse
03/21/03 AptarGroup : Completes Deal to Buy Nearly 65% of Voluntis; Mandatory Takeover Offer to Commence MT
03/21/03 AptarGroup : Completes Acquisition of Majority Stake in Voluntis MT
03/21/03 Voluntis S.A. Announces Executive Changes CI
02/21/02 AptarGroup, Inc. made an offer to acquire remaining 35.4% stake in Voluntis S.A. for €27.4 million. CI
02/21/02 AptarGroup, Inc. completed the acquisition of 64.6% stake in Voluntis S.A. from Vesalius Biocapital Partners S.à r.l, LBO France, Sham Innovation Santé, Bpifrance Participations SA, Debiopharm Innovation Fund SA and Eric Carreel. CI
26/21/26 AptarGroup : Signs Deal to Buy Majority Stake in Digital Therapeutics Firm Voluntis for 8.70 Euros Per Share MT
23/21/23 AptarGroup, Inc. signed a share purchase agreement to acquire 64.6% stake in Voluntis S.A. from Vesalius Biocapital Partners S.à r.l, LBO France, Sham Innovation Santé, Bpifrance Participations SA, Debiopharm Innovation Fund SA and Eric Carreel for €50.1 million. CI
30/21/30 Linklaters Advises Aptar on Entering into Exclusive Negotiations Regarding A Potential Acquisition of Voluntis CI
22/21/22 Voluntis Enters into Exclusive Negotiations with AptarGroup CI
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 01/01/2001
Corporate Officer/Principal 47 01/01/2001
Chief Executive Officer 48 01/01/2001
Director TitleAgeSince
Chairman 48 01/01/2001
Director/Board Member 66 -
Chairman 62 15/06/2015
Date Insider Type Main position Quantity % Market Cap.
08/21/08
LBO France Gestion SAS
SellCompany 6,81,267 7.5255%
07/21/07Sell

Founder

83,338 0.9206%
07/21/07
BPIFrance Participations SA /PRIVATE EQUITY/
SellCompany 18,90,974 20.8882%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-0.11% - - 9.12Cr
-7.60%-14.00%+35.78%+2,198.50% 17TCr
-2.90%-9.24%-42.85%-47.60% 9.62TCr
-0.35%+0.23%+37.82%+60.77% 5.08TCr
-0.43%-5.32%-24.61%+11.27% 4.73TCr
-2.46%-5.81%-44.55%-31.39% 3.46TCr
+0.49%-0.34%-41.48%-25.77% 3.38TCr
+0.66%-3.77%-19.52%-1.15% 1.58TCr
-0.90%-8.33%-33.73%-4.07% 1.35TCr
-2.04%-8.46%-60.01%-32.39% 941.4Cr
Average -0.60%-6.27%-21.46%+236.46% 5.29TCr
Weighted average by Cap. -0.85%-8.51%-2.90%+800.51%
Logo Voluntis S.A.
Voluntis SA is a France-based company specialized in medical solutions. The Company designs prescription applications that embed medical intelligence in the smart phones of people suffering from chronic and rare diseases. Voluntis SA develops digital solutions for diabetes, respiratory diseases, cancer, anticoagulation and hemophilia. Its product portfolio includes Insulia, a prescription-only medical device, which is a digital therapeutic for people with type 2 diabetes who are being treated with long-acting basal insulin. The medical device also provides patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; Theraxium platform, which is a flexible platform that transforms health data into medical intelligence, and Quality and Regulatory Expertise, which focuses on patient safety, among others.
Employees
74
  1. Stock Market
  2. Stocks
  3. ALVTX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW